NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Jun Wang
University at Buffalo - Buffalo / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5344796
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Jun Wang's MOST POPULAR ARTICLES
1-)
Development of a target cell-biologics-effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agentsX Jiang, X Chen, TJ Carpenter, J Wang, R Zhou, HM Davis, DL Heald, ...MAbs 10 (6), 876-889, 2018442018
2-)
Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP modelH Ma, H Wang, RJ Sové, J Wang, C Giragossian, AS PopelJournal for immunotherapy of cancer 8 (2), 2020382020
3-)
Tumor priming by SMO inhibition enhances antibody delivery and efficacy in a pancreatic ductal adenocarcinoma modelJ Wang, DKW Chan, A Sen, WW Ma, RM StraubingerMolecular cancer therapeutics 18 (11), 2074-2084, 2019342019
4-)
A quantitative systems pharmacology model of T cell engager applied to solid tumorH Ma, H Wang, RJ Sove, M Jafarnejad, CH Tsai, J Wang, C Giragossian, ...The AAPS Journal 22, 1-16, 2020302020
5-)
Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancerMK Greene, T Chen, E Robinson, NL Straubinger, C Minx, DKW Chan, ...British Journal of Cancer 123 (10), 1502-1512, 2020182020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept